Zobrazeno 1 - 10
of 201 633
pro vyhledávání: ''
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:122-131
Background: Gastric cancer (GC) is a common tumor found worldwide, and cisplatin is the first-line agent for the treatment of GC. However, the resistance to cisplatin is an obstacle. Here, we aim to explore the biological mechanism of long noncoding
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:132-139
Background: The procancer effect of TEA domain transcription factor 4 (TEAD4) has been gradually discovered. However, its expression in esophageal cancer (EC) cells and its effect on proliferation ...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:927-938
Background: Colorectal cancer (CRC) is a significant public problem and the third cause of cancer-induced death all over the world. In addition, long noncoding RNA (lncRNA) has been reported as a vital mediator in human cancer. However, the precise r
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:955-962
Objectives: With the aging population worldwide, the octogenarians are becoming a substantial group and since cancer incidence increases by age, this group of patients is becoming more affected. Ho...
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 37:871-881
Background: Colorectal cancer (CRC) is the third most common malignancy worldwide. Matrine can act as a potential antitumor drug, and its antitumor activities have been tested in various cancers, including CRC. However, the effect of matrine and the
Autor:
Victoria Damerell, Danica Sims, Jade Peres, Sharon Prince, Ashwin W Isaacs, Dhirendra Govender, Hapiloe Mabaruti Maranyane
Publikováno v:
Cancers
Volume 12
Issue 2
Cancers, Vol 12, Iss 2, p 501 (2020)
Volume 12
Issue 2
Cancers, Vol 12, Iss 2, p 501 (2020)
Rhabdomyosarcoma is a highly aggressive malignant cancer that arises from skeletal muscle progenitor cells and is the third most common solid tumour in children. Despite significant advances, rhabdomyosarcoma still presents a therapeutic challenge, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d760b632cd2425abbfdffe3b0da24795
https://doi.org/10.3390/cancers12020501
https://doi.org/10.3390/cancers12020501
Publikováno v:
Cancer Immunology, Immunotherapy
Target expression heterogeneity and the presence of an immunosuppressive microenvironment can hamper severely the efficiency of immunotherapeutic approaches. We have analyzed the potential to encounter and overcome such conditions by a combinatory tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c705f9058459f0ab911c54595b9554fb
Autor:
Sheetal Kashyap, Sasanka Chakrabarti, Adesh K. Saini, Neeraj K. Saini, Vipin Saini, Gourav Chandan, Vijay Kumar Thakur, Amit Mittal, Reena V. Saini, Soumya Pal
Publikováno v:
Seminars in Cancer Biology. 86:643-651
The interaction between gut microbes and gastrointestinal (GI) tract carcinogenesis has always attracted researchers' attention to identify therapeutic targets or potential prognostic biomarkers. Various studies have suggested that the microbiota do
Autor:
Sabia Rashid, Atul Chikara, Alexandre Gomes Rodrigues, Sandeep Sisodiya, Sheeraz Un Nazir, Shazia Rashid, Pranay Tanwar, Ajit Kumar Passari, Asiya Khan, Umme Abiha, Showket Hussain, Ankan Mukherjee Das, Bhudev C. Das
Publikováno v:
Seminars in Cancer Biology. 86:583-589
The persistent infection of high-risk Human papillomavirus (HR-HPV) induced cervical cancer remains a challenge in women worldwide including India. Recent advances in cancer research have paved the way for advanced cancer treatment modalities includi
Autor:
Arul Goel, Amit Kumar Pandey, Aishwarya Singh, Manoj Garg, Gautam Sethi, Kanchugarakoppal S. Rangappa, Simran Tandon, Chakrabhavi Dhananjaya Mohan, Gouri Pandya, Anuradha Kirtonia, Sonia Kapoor
Publikováno v:
Seminars in Cancer Biology. 86:682-692
Pancreatic carcinoma is associated with one of the worst clinical outcomes throughout the globe because of its aggressive, metastatic, and drug-resistant nature. During the past decade, several studies have shown that oral, gut, and tumor microbiota